50-07-7 | Mitomycin C

Chemical type

• Antitumor antibiotic
• Alkylating agent

Key properties

• DNA cross-linking agent
• Chemotherapeutic agent

• Chemotherapy drug for high-risk liver hepatocellular carcinoma (HCC) patients
• Shown to have greater sensitivity in treating high-risk HCC patients

Classification by use

• Chemotherapy drugs

A trustworthy factory and manufacturer

Demei Chemical Technology Co., Ltd. is a modern high-tech enterprise integrating R&D, production, and sales. The company's founder, Dr. Arron, born in April 1975, graduated from the School of Mechanical Engineering at Yanshan University and has been engaged in research in the fields of mechanical engineering and chemical synthesis for many years. The company's products focus on the chemical industry, primarily dealing in chemical raw materials and chemical production machinery and equipment. With its strong technical capabilities, advanced production equipment, and strict quality management system, the company has earned the trust of customers worldwide.

1. Anoikis- and m6A-related lncRNA analysis to identify prognostic indicators in liver hepatocellular carcinoma, Electronic Journal of Biotechnology, Volume 79, January 2026, 100701